Magenta Therapeutics (NASDAQ:MGTA) reported quarterly losses of $(0.29) per share. This is a 9.38 percent increase over losses of $(0.32) per share from the same period last year.
FREYR Battery Announces Public Offering of 13.5M Ordinary Shares, No Terms Disclosed
FREYR Battery (NYSE:FREY) ("FREYR"), a developer of clean, next-generation battery cell production capacity, today announced that it plans to make a public offering of 13,500,000 of its Ordinary Shares, without